Rocket Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference Apr 3, 2025 07:00AM
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress Feb 26, 2024 04:01PM
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences Apr 11, 2023 04:01PM
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial and Operational Results Feb 27, 2023 04:01PM
Needham & Company Reiterates Buy Rating, $75 Price Target on Rocket Pharmaceuticals (RCKT) May 6, 2022 05:55AM


Apr 12, 2022 06:20AM Needham & Company Reiterates Buy Rating on Rocket Pharmaceuticals (RCKT), Sees RP-A501 as "Major Value Driver"
Mar 29, 2022 07:00AM Rocket Pharmaceuticals to Present at Upcoming Investor Conferences
Feb 24, 2022 07:00AM Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial and Operational Results
Feb 18, 2021 07:39AM Needham & Company Starts Rocket Pharmaceuticals (RCKT) at Buy
Apr 16, 2019 09:29AM Pre-Open Stock Movers 04/16: (ELF) (CRSP) (GH) Higher; (BRS) (WVE) (IP) Lower (more...)